|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 3179 |
FusionGeneSummary for ATG2B_SLC22A17 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ATG2B_SLC22A17 | Fusion gene ID: 3179 | Hgene | Tgene | Gene symbol | ATG2B | SLC22A17 | Gene ID | 55102 | 51310 |
| Gene name | autophagy related 2B | solute carrier family 22 member 17 | |
| Synonyms | C14orf103 | 24p3R|BOCT|BOIT|NGALR|NGALR2|NGALR3|hBOIT | |
| Cytomap | 14q32.2 | 14q11.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | autophagy-related protein 2 homolog BATG2 autophagy related 2 homolog B | solute carrier family 22 member 1724p3 receptorNGAL receptorbrain-type organic cation transporterlipocalin-2 receptorneutrophil gelatinase-associated lipocalin receptorpotent brain type organic ion transportersolute carrier family 22 (organic catio | |
| Modification date | 20180527 | 20180522 | |
| UniProtAcc | Q96BY7 | Q8WUG5 | |
| Ensembl transtripts involved in fusion gene | ENST00000359933, ENST00000261834, | ENST00000354772, ENST00000397260, ENST00000474057, ENST00000206544, ENST00000397267, | |
| Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 3 X 3 X 2=18 |
| # samples | 3 | 3 | |
| ** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: ATG2B [Title/Abstract] AND SLC22A17 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | BLCA | TCGA-DK-A3IK-01A | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000359933 | ENST00000354772 | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
| Frame-shift | ENST00000359933 | ENST00000397260 | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
| 5CDS-5UTR | ENST00000359933 | ENST00000474057 | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
| 5CDS-5UTR | ENST00000359933 | ENST00000206544 | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
| 5CDS-5UTR | ENST00000359933 | ENST00000397267 | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
| intron-3CDS | ENST00000261834 | ENST00000354772 | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
| intron-3CDS | ENST00000261834 | ENST00000397260 | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
| intron-5UTR | ENST00000261834 | ENST00000474057 | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
| intron-5UTR | ENST00000261834 | ENST00000206544 | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
| intron-5UTR | ENST00000261834 | ENST00000397267 | ATG2B | chr14 | 96782870 | - | SLC22A17 | chr14 | 23816145 | - |
Top |
FusionProtFeatures for ATG2B_SLC22A17 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ATG2B | SLC22A17 |
| Required for both autophagosome formation and regulationof lipid droplet morphology and dispersion.{ECO:0000269|PubMed:22219374}. | Cell surface receptor for LCN2 (24p3) that plays a keyrole in iron homeostasis and transport. Able to bind iron-boundLCN2 (holo-24p3), followed by internalization of holo-24p3 andrelease of iron, thereby increasing intracellular ironconcentration and leading to inhibition of apoptosis. Also bindsiron-free LCN2 (apo-24p3), followed by internalization of apo-24p3and its association with an intracellular siderophore, leading toiron chelation and iron transfer to the extracellular medium,thereby reducing intracellular iron concentration and resulting inapoptosis (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ATG2B_SLC22A17 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ATG2B_SLC22A17 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ATG2B | ATG2A, WDR45, HDAC11, MLF1, TALDO1, LHX6, NTRK1, MED4, CEP89, POC1A, ZSCAN26, DUSP26, SALL2, NPAS1, ARHGAP36, SKP2, TKT, C6orf141, BRINP3, AP1G2, SLAMF1, DOCK5, SNX21, DEF8, USP15, SPAG9, MCM2, MCM4, MCM6 | SLC22A17 | MCM2 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ATG2B_SLC22A17 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ATG2B_SLC22A17 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ATG2B | C0023470 | Myeloid Leukemia | 1 | CTD_human |
| Hgene | ATG2B | C0027022 | Myeloproliferative disease | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|